In recent years lignans have gained great importance because of their biological activities These are anticancer antiviral, cathartic and allergenic activities. The most important of these is their anticancer activity This review includes lignans which show this activity and established the relationship between some lignan structures and their activites.
INTRODUCTION
From earliest times, plants have been used for medicinal purposes and to treat diseases. Egyptian pictographs, Babylonian clay tablet ideographs and Sumerian tablets have all shown that plants were used in the preparation of remedies From about 3000 B.C. the Sumerians used plants like Cassia and Thymus to make laxatives, antiseptics and other medicinal products (1) .
The Greeks also contributed to this tradition, particularly with the studies of Dioscorides, a physician who lived in the first century.
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He wrote The Materia Medica, which lists over 600 plants that could be used for medicinal purposes, some of which are still important in modern medicine: These plants include Aloe, Atropa, Colchicum, Hyoscyamus and Papaver. Galen, a Greek pharmacist-physician, conducted similar researches and published about twenty books on the preparation of drugs (2) . Other important contributors were the Chinese, whose Emperor Shen Nung wrote the "Pen Tsao Ching" around 2700 B.C. in which he described a hundred herbal remedies. Even today the Chinese still use many traditional medicinal techniques involving herbal remedies (2).
One very important area of research exploits the use of plants in the treatment of cancer. Cancer is the second most common cause of death after cardiovascular disease in Europe and USA. Therefore attempts are being made to isolate active constituents from natural sources that could be used to treat this very serious illness (3) . Man has suffered from cancer for more than a million years. Evidence for this has been found by examination of an anthropoid unearthed in Java in 1891 (1).
Bone cancer was identified in some mummies in the pyramid of Gizeh. Ebers papyrus (1500 B.C.) also described symptoms of cancer and some primitive treatments. For example, for the treartment of abnormal hardening of a tissue or organ the external application of garlic (Allium sativum). Hippocrates, about 400 B.C. described many kinds of cancer and the application of some plant derived pastes for their cure. Garlic was also mentioned by him for the treatment of uterine tumours (1) . Today, there is scientific evidence to show that garlic can be used against cancers of the skin, colon and stomach (5) .
Two plant species which have a similar historical background are Sanguinaria canadensis and Podophyllum peltatum. These two plants were originally used by the North American Indians to treat cancer. Research on these plants has shown that some alkaloids isolated from S. canadensis have a significant effect on cancer cells (6) . Chemical investigation of the resin of Podophyluml species has revealed the presence of several lignans, including podophyllotoxin, a-peltatin and 5-peltatin which show antitumour activity in mice (7) . Further examples can. be found in. other plant species. Therefore it will be useful to study folkloric remedies when starting the chemical investigation of other plant species. Lignans have been identified in some families many of which have been used in folk medicine. They have been isolated from all parts of plants (wood, bark, resin, roots, leaves, flowers, fruits and seeds) (7, 8) .
There can be no doubt that the lignans have provided interesting examples of plant antitumour agents. Since 1942 the lignans have been of interest any numerous studies have been made on podophyllotoxin Antitumour activities of the other classes of lignans are also important. For example, burseran, a mono epoxylignan obtained from Bursera microphylla (Burseraceae) has also shown cytotoxic activity (10) . A species, Penstemon deustus, which belongs to the Family Scrophulariaceae contains a furofuranoid lignan liriodendrin which can be used as a cytotoxic agent (11) . Styraxin, another a furofuran lignan, isolated from Styrax officinalis (Styraxaceae), also has antitumour activity (12) . In 1989 Trumm and Eich reported that the two benzylbutyrolactones, arctigenin and trachelogenin, showed strong cytotoxic activity. These two lignans have been isolated from Ipomoea cairica (Convolvulaceae) (13) . Diphyllin is one of the arylnaphthalene derivatives which has cytostatic activity. This powerful action may be related to its close structural relationship with podophyllotoxin (14) . Diphyllin. has been obtained from Diphylleia grayi (15) . D. cymosa (Berberidaceae: Podophylloidea), Justicia procumbens (Acanthaceae) (16) , Cleistanthus collinus (Euphorbiaceae) (17, 18) . Taiwania cryptomeriodides (Cupressaceae) (19) , and four Haplophyllum species (Rutaceae), H. buxbaumi (20) . H. tuberculatum (14) , H. hispanicum (21) and H. cappadocicum (22) . 5-methoxypodophyllotoxin and podophyllotoxin have been isolated from Linum album (23) .
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Two lignan lactones of the dibenzocyclooctadiene type, known as steganacin and steganagin, have significant cytotoxic activity both in vivo and in vitro These compounds have been obtained from an alcoholic extract of the South African tree Steganotaenia araliaceae (Umbelliferae) (24) .
Anti-leukaemic action has been reported for wisktromol isolated from Wikstroemia viridi-flora (25) .
So far, 36 anticancer lignans have been identified and these are listed in Table 1 . 
STRUCTURE-ACTIVITY RELATIONSHIPS PODPHYLLTOXIN AND RELATED COMPOUNDS
Lignans have great significance because of their anticancer activity. This is particularly true of the Podophyliotoxin group of lignans. There is no set structural trend which might explain some of the activity of lignans as anticancer agents. Many of the active forms do show the following features.
1. 5-membered lactone rings. The presence of a lactone is a common feature but its role in the anti-tumour activity of lignans is not clear e.g. burseran possesses a furan ring rather than a lactone ring and displays a degree of activity. Also it does not seem to picropodophyllin and picropodophyllic acid are both weakly active.
A major proportion of active lignans do not possess the 3, 4, 5 trimethoxyphenyl moiety which shows that it is not an essential re quirement for activity. The methylenedioxyphenyl residue plays an important role in activity as many anti-tumour lignans possess this attachment. The basic skeleton of the active lignan is difficult to relate to its antitumour potential. It has been suggested that the skeleton layout may be an important factor with particular regard to podophyllotoxin but there is no particular trend shown in comparison with similar lignan structures.
To illustrate the above analysis, a study of the structure-activity relationships of podophyllotoxin and its analogues has shown the following trends:
1. The configuration at C-4 seems to be important e.g., epipodophyllotoxin, is 10 times less active than its primer.
2. An OH group at C-5 rather than C-4 seems to increase activity e.g., -peltatin is more potent than podophyllotoxin.
3. The hydroxyl group at C-4 does not seem to be essential since desoxypodophyllotoxin and -and -peltatin are all active. 5. The configuaration at C-2 plays a significant role in antitumour activity e.g., picropodophyllin has greatly decreased cytotoxic activity.
6. Substituting a furan ring for the lactone of podophyllotoxin greatly reduces antitumour activity.
7. The polarity of substituents at C-4 are more important than their steric effect for anti-tumour activity e.g., 5-methoxypodophyllotoxin glucoside is less active than its aglycone.
8. The three methoxy groups on the pendant ring do not seem to be essential for antitumour activity e.g., 4'-demethylpodophyllotoxin has almost the same activity as podophyllotoxin.
podohyllotoxin glucoside

Conclusion
Plant products have been used to treat cancer for many years. Forinstance, podophyllotoxins and other types of lignans have shown evidence of acticancer activity. Further studies will lead researchers to continue to uncover new active structures and several new compounds from plants which may be used in clinical trials. Perhaps future the plants will play an even more significant role than they do now.
